Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS

AIM: To describe the long-term outcomes of patients with lymphoma in the CNS treated with rituximab, temozolomide and high-dose methotrexate without consolidation therapy. PATIENTS & METHODS: A retrospective cohort study of 46 consecutive patients with primary CNS lymphoma (PCNSL, 27 patients) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagle, Sarah J, Shah, Nirav N, Ganetsky, Alex, Landsburg, Daniel J, Nasta, Sunita D, Mato, Anthony, Schuster, Stephen J, Reshef, Ran, Tsai, Donald E, Svoboda, Jakub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171986/
https://www.ncbi.nlm.nih.gov/pubmed/30302232
http://dx.doi.org/10.2217/ijh-2017-0020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171986/
https://www.ncbi.nlm.nih.gov/pubmed/30302232
http://dx.doi.org/10.2217/ijh-2017-0020

Ejemplares similares